Related Experiment Video
Updated: Aug 11, 2025

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
Published on: April 28, 2020
Pattern of liver function test variations in COVID-19 infection & its clinical significance: A study from a dedicated
Sanjay J Chandnani1, Shubham Jain1, Pankaj Nawghare1
1Department of Gastroenterology, Topiwala National Medical College & Bai Yamunabai Laxmanrao Nair Charitable Hospital, Mumbai, Maharashtra, India.
Insights
Liver function test abnormalities are common in COVID-19 patients and indicate a higher risk of severe disease and mortality. Deranged LFTs worsen outcomes and predict in-hospital death.
Area of Science:
- Hepatology
- Infectious Diseases
- Internal Medicine
Background:
- Coronavirus disease 2019 (COVID-19) can affect multiple organ systems, including the liver.
- Data on liver involvement and liver function test (LFT) abnormalities in COVID-19 patients from India are limited.
Purpose of the Study:
- To estimate the prevalence and characteristics of LFT abnormalities in COVID-19 patients.
- To investigate the association between LFT derangements and disease severity, clinical outcomes, and mortality.
Main Methods:
- Retrospective study of 1474 COVID-19 patients confirmed by RT-PCR at a tertiary care center in Mumbai, India.
- Analysis of clinical characteristics, biochemical parameters (including LFTs), and patient outcomes.
- Multivariate analysis to identify predictors of mortality.
Main Results:
- 46% of patients exhibited deranged LFTs, predominantly hepatocellular injury (93%).
- Deranged LFTs were significantly associated with increased risk of severe disease (P<0.001) and mortality (P<0.001).
- Factors associated with deranged LFTs included advanced age, male gender, diabetes, low oxygen saturation, and high neutrophil-lymphocyte ratio.
Conclusions:
- LFT abnormalities are frequent in COVID-19 patients and correlate with disease severity.
- Deranged LFTs are indicative of poorer clinical outcomes and predict in-hospital mortality.
Background & Objectives:
Coronavirus disease 2019 (COVID-19) affects respiratory, gastrointestinal, cardiovascular and other systems disease. Studies describing liver involvement and liver function test (LFT) abnormalities are sparse from our population. This study was undertaken to estimate the LFT abnormalities in patients with COVID-19 in a tertiary care set up in India.
Methods:
In this retrospective study conducted at a tertiary care centre in Mumbai, India, all consecutive patients with proven COVID-19 by reverse transcriptase-PCR from March 23 to October 31, 2020 were enrolled. Of the 3280 case records profiled, 1474 cases were included in the study. Clinical characteristics, biochemical parameters and outcomes were recorded.
Results:
Overall 681 (46%) patient had deranged LFTs. Hepatocellular type of injury was most common (93%). Patients with deranged LFTs had more probability of developing severe disease (P<0.001) and mortality (P<0.001). Advanced age (P<0.001), male gender (P<0.001), diabetes mellitus (P<0.001), lower oxygen saturation levels at admission (P<0.001), higher neutrophil-lymphocyte ratio (P<0.001), history of diabetes mellitus and cirrhosiss were associated with deranged LFTs. Acute liver injury was seen in 65 (4.3%) cases on admission and 57 (3.5%) cases during hospital stay. On multivariate analysis for predicting mortality, age >60 yr serum creatinine >2 mg%, PaO2/FiO2 ratio ≤200 and raised AST >50 IU/l (OR: 2.34, CI: 1.59-3.48, P<0.001) were found to be significant.
Interpretation & Conclusions:
In COVID-19, LFT abnormalities were common, and derangement increased as severity progressed. The presence of deranged LFT worsens the clinical outcome and predicts in-hospital mortality.
Related Concept Videos
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Serum Studies: Renal Function Tests
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Myocarditis II: Clinical Features and Diagnostic Tests
Serum Laboratory Studies, Stool Test, Breath Test

